328 related articles for article (PubMed ID: 20080896)
21. An iterative technique to segment PET lesions using a Monte Carlo based mathematical model.
Nehmeh SA; El-Zeftawy H; Greco C; Schwartz J; Erdi YE; Kirov A; Schmidtlein CR; Gyau AB; Larson SM; Humm JL
Med Phys; 2009 Oct; 36(10):4803-9. PubMed ID: 19928110
[TBL] [Abstract][Full Text] [Related]
22. Simulated FDG-PET studies for the assessment of SUV quantification methods.
Silva-Rodríguez J; Aguiar P; Domínguez-Prado I; Fierro P; Ruibal Á
Rev Esp Med Nucl Imagen Mol; 2015; 34(1):13-8. PubMed ID: 25107595
[TBL] [Abstract][Full Text] [Related]
23. Noise considerations for PET quantification using maximum and peak standardized uptake value.
Lodge MA; Chaudhry MA; Wahl RL
J Nucl Med; 2012 Jul; 53(7):1041-7. PubMed ID: 22627001
[TBL] [Abstract][Full Text] [Related]
24. Using 18F-fluorodeoxyglucose positron emission tomography to estimate the length of gross tumor in patients with squamous cell carcinoma of the esophagus.
Zhong X; Yu J; Zhang B; Mu D; Zhang W; Li D; Han A; Song P; Li H; Yang G; Kong FM; Fu Z
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):136-41. PubMed ID: 18538492
[TBL] [Abstract][Full Text] [Related]
25. Effects of image characteristics on performance of tumor delineation methods: a test-retest assessment.
Cheebsumon P; van Velden FH; Yaqub M; Frings V; de Langen AJ; Hoekstra OS; Lammertsma AA; Boellaard R
J Nucl Med; 2011 Oct; 52(10):1550-8. PubMed ID: 21849398
[TBL] [Abstract][Full Text] [Related]
26. 18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense?
Hellwig D; Graeter TP; Ukena D; Groeschel A; Sybrecht GW; Schaefers HJ; Kirsch CM
J Nucl Med; 2007 Nov; 48(11):1761-6. PubMed ID: 17942814
[TBL] [Abstract][Full Text] [Related]
27. [3D volume and SUV analysis of oncological PET studies: a voxel-based image processing tool with NSCLC as example].
Krohn T; Kaiser HJ; Gagel B; Boy C; Schaefer WM; Buell U; Zimny M
Nuklearmedizin; 2007; 46(4):141-8. PubMed ID: 17690792
[TBL] [Abstract][Full Text] [Related]
28. The effect of tumor size on the imaging diagnosis: a study based on simulation.
Qiao H; Wang L; Li D; Wang D; Wang Y
Biomed Mater Eng; 2014; 24(6):3129-36. PubMed ID: 25227022
[TBL] [Abstract][Full Text] [Related]
29. Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error?
Yau YY; Chan WS; Tam YM; Vernon P; Wong S; Coel M; Chu SK
J Nucl Med; 2005 Feb; 46(2):283-91. PubMed ID: 15695788
[TBL] [Abstract][Full Text] [Related]
30. Repeatability of metabolically active tumor volume measurements with FDG PET/CT in advanced gastrointestinal malignancies: a multicenter study.
Frings V; van Velden FH; Velasquez LM; Hayes W; van de Ven PM; Hoekstra OS; Boellaard R
Radiology; 2014 Nov; 273(2):539-48. PubMed ID: 24865311
[TBL] [Abstract][Full Text] [Related]
31. Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.
Chen W; Cloughesy T; Kamdar N; Satyamurthy N; Bergsneider M; Liau L; Mischel P; Czernin J; Phelps ME; Silverman DH
J Nucl Med; 2005 Jun; 46(6):945-52. PubMed ID: 15937304
[TBL] [Abstract][Full Text] [Related]
32. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer.
Ashamalla H; Rafla S; Parikh K; Mokhtar B; Goswami G; Kambam S; Abdel-Dayem H; Guirguis A; Ross P; Evola A
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1016-23. PubMed ID: 15979817
[TBL] [Abstract][Full Text] [Related]
33. Partial volume correction and image segmentation for accurate measurement of standardized uptake value of grey matter in the brain.
Bural G; Torigian D; Basu S; Houseni M; Zhuge Y; Rubello D; Udupa J; Alavi A
Nucl Med Commun; 2015 Dec; 36(12):1249-52. PubMed ID: 26426967
[TBL] [Abstract][Full Text] [Related]
34. 18F-FDG PET of common enhancing malignant brain tumors.
Kosaka N; Tsuchida T; Uematsu H; Kimura H; Okazawa H; Itoh H
AJR Am J Roentgenol; 2008 Jun; 190(6):W365-9. PubMed ID: 18492879
[TBL] [Abstract][Full Text] [Related]
35. Is liver SUV stable over time in ¹⁸F-FDG PET imaging?
Laffon E; Adhoute X; de Clermont H; Marthan R
J Nucl Med Technol; 2011 Dec; 39(4):258-63. PubMed ID: 21878481
[TBL] [Abstract][Full Text] [Related]
36. Variability and uncertainty of 18F-FDG PET imaging protocols for assessing inflammation in atherosclerosis: suggestions for improvement.
Huet P; Burg S; Le Guludec D; Hyafil F; Buvat I
J Nucl Med; 2015 Apr; 56(4):552-9. PubMed ID: 25722452
[TBL] [Abstract][Full Text] [Related]
37. Repeatability of 18F-FDG uptake measurements in tumors: a metaanalysis.
de Langen AJ; Vincent A; Velasquez LM; van Tinteren H; Boellaard R; Shankar LK; Boers M; Smit EF; Stroobants S; Weber WA; Hoekstra OS
J Nucl Med; 2012 May; 53(5):701-8. PubMed ID: 22496583
[TBL] [Abstract][Full Text] [Related]
38. Computer-aided detection (CAD) and assessment of malignant lesions in the liver and lung using a novel PET/CT software tool: initial results.
Hahn S; Heusner T; Zhou X; Zhan Y; Peng Z; Hamami M; Forsting M; Bockisch A; Antoch G
Rofo; 2010 Mar; 182(3):243-7. PubMed ID: 19859858
[TBL] [Abstract][Full Text] [Related]
39. Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5.
Hashimoto Y; Tsujikawa T; Kondo C; Maki M; Momose M; Nagai A; Ohnuki T; Nishikawa T; Kusakabe K
J Nucl Med; 2006 Mar; 47(3):426-31. PubMed ID: 16513611
[TBL] [Abstract][Full Text] [Related]
40. Adrenal masses in patients with cancer: PET/CT characterization with combined CT histogram and standardized uptake value PET analysis.
Perri M; Erba P; Volterrani D; Guidoccio F; Lazzeri E; Caramella D; Mariani G
AJR Am J Roentgenol; 2011 Jul; 197(1):209-16. PubMed ID: 21701032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
